BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1048 related articles for article (PubMed ID: 9130941)

  • 1. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1997 Apr; 349(9060):1202-9. PubMed ID: 9130941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1996 Aug; 348(9026):498-505. PubMed ID: 8757151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1996 Aug; 348(9026):505-10. PubMed ID: 8757152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1995 Dec; 346(8990):1575-82. PubMed ID: 7500748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
    Lewis MA; Heinemann LA; Spitzer WO; MacRae KD; Bruppacher R
    Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives and myocardial infarction: results of the MICA case-control study.
    Dunn N; Thorogood M; Faragher B; de Caestecker L; MacDonald TM; McCollum C; Thomas S; Mann R
    BMJ; 1999 Jun; 318(7198):1579-83. PubMed ID: 10364115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined oral contraceptives, smoking, and cardiovascular risk.
    Farley TM; Meirik O; Chang CL; Poulter NR
    J Epidemiol Community Health; 1998 Dec; 52(12):775-85. PubMed ID: 10396518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptive pills and the risk of venous thromboembolism.
    Prog Hum Reprod Res; 1996; (39):2-3. PubMed ID: 12292198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent studies confirm the safety of oral contraceptives with respect to stroke.
    Contracept Rep; 1996 Nov; 7(4):4-9. PubMed ID: 12291813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
    Heinemann LA; Lewis MA; Thorogood M; Spitzer WO; Guggenmoos-Holzmann I; Bruppacher R
    BMJ; 1997 Dec; 315(7121):1502-4. PubMed ID: 9420491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
    United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
    Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epidemiologic survey of cardiovascular disease in women taking oral contraceptives.
    Thorogood M; Vessey MP
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):274-81. PubMed ID: 2196799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
    Schwingl PJ; Ory HW; Visness CM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.